B · Normal
On October 30, documents showed that India’s drug regulatory agency asked Sun Pharmaceuticals (SUN.NS) to stop the production and sales of all ophthalmic products produced at its Assam factory.
Related telegraphs
On October 30, AbbVie expected full-year adjusted earnings per share of 13.95 to
10-30 19:48
[Hangzhou Qiantang District has set up 38 biopharmaceutical sub-funds with a tot
10-30 19:11
On October 30, Morgan Stanley raised Eli Lilly’s target price from $1,430 to $1,
10-30 15:43
[National Medical Insurance Administration: Reasonably adjust the price of medic
10-30 14:55
On October 29th, Eli Lilly's shares rose more than 5% before the market opened.
10-29 18:48
On October 29th, Moderna CEO said that its skin cancer drug may be launched in G
10-29 17:19
Comments